Cornercap Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,028
Closed -$2.18M 570
2023
Q1
$2.18M Buy
9,028
+210
+2% +$51.5K 0.38% 52
2022
Q4
$2.32M Sell
8,818
-791
-8% -$212K 0.4% 49
2022
Q3
$2.17M Sell
9,609
-449
-4% -$109K 0.41% 46
2022
Q2
$2.45M Buy
10,058
+582
+6% +$143K 0.42% 43
2022
Q1
$2.29M Buy
9,476
+447
+5% +$103K 0.26% 84
2021
Q4
$2.03M Sell
9,029
-667
-7% -$141K 0.29% 86
2021
Q3
$2.06M Sell
9,696
-295
-3% -$67.9K 0.24% 105
2021
Q2
$2.44M Sell
9,991
-142
-1% -$34.9K 0.27% 95
2021
Q1
$2.52M Buy
+10,133
New +$2.42M 0.28% 95
2020
Q4
Sell
-9,947
Closed -$2.53M 435
2020
Q3
$2.53M Buy
9,947
+16
+0.2% +$3.96K 0.36% 88
2020
Q2
$2.34M Buy
+9,931
New +$2.27M 0.38% 95
2019
Q3
Sell
-33,714
Closed -$6.21M 393
2019
Q2
$6.21M Sell
33,714
-378
-1% -$67.7K 0.82% 7
2019
Q1
$6.48M Sell
34,092
-253
-0.7% -$48.3K 0.9% 5
2018
Q4
$6.69M Sell
34,345
-1,618
-4% -$316K 1.03% 2
2018
Q3
$7.46M Sell
35,963
-1,160
-3% -$229K 0.98% 6
2018
Q2
$6.85M Sell
37,123
-1,100
-3% -$195K 0.98% 7
2018
Q1
$6.52M Sell
38,223
-1,127
-3% -$207K 0.93% 12
2017
Q4
$6.84M Sell
39,350
-29
-0.1% -$5.13K 0.94% 14
2017
Q3
$7.34M Buy
39,379
+8,324
+27% +$1.47M 1.03% 8
2017
Q2
$5.35M Buy
31,055
+720
+2% +$117K 0.9% 23
2017
Q1
$4.98M Buy
30,335
+95
+0.3% +$15.8K 0.84% 29
2016
Q4
$4.42M Buy
30,240
+19,010
+169% +$2.86M 0.76% 33
2016
Q3
$1.87M Buy
11,230
+2,560
+30% +$433K 0.34% 78
2016
Q2
$1.32M Buy
8,670
+3,800
+78% +$591K 0.25% 96
2016
Q1
$730K Buy
4,870
+1,720
+55% +$256K 0.14% 114
2015
Q4
$512K Buy
3,150
+275
+10% +$43.2K 0.1% 153
2015
Q3
$397K Buy
+2,875
New +$453K 0.08% 247

Other funds holding AMGN

Cornercap Investment Counsel's AMGN Position: Q2 2023 in Review

Cornercap Investment Counsel sold out of Amgen (AMGN) in Q2 2023, closing a stake of 9,028 shares — an estimated $2.18M sold.

Cornercap Investment Counsel first reported a position in AMGN in Q3 2015 and held it in 27 quarters. The position peaked at $7.46M in Q3 2018. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Cornercap Investment Counsel reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 9,028 Amgen shares in Q2 2023, an estimated $2.18M.
  • Cornercap Investment Counsel first reported a position in Amgen in Q3 2015 and held it in 27 quarters.
  • Cornercap Investment Counsel's Amgen position peaked at $7.46M in Q3 2018.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Cornercap Investment Counsel's 13F filing for Q2 2023, filed 11 Aug 2023.